Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial
Assessed by RV013 · Clinical Chair in Health Services Research
Assessed on 16 Nov 2025
OverallReviewer's overall integrity assessment, derived from all research questions Some concerns
DOI 10.1136/bmj-2025-084314 (opens in new tab)
Resource ripekg:research-integrity-assessment/RIPEA0A4B2238CEE31171
5 Research Questions · 65 Evidence Items
Q1.1 — Does the study have an associated retraction?
Rationale: No notice on journal page
Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?
Rationale: No notice on journal page.
Q1.3 — Do other studies by the research team highlight causes for concern?
Rationale: Too many authors with same name on RW's database, needs further evaluation.
Supporting Evidence (63)
Retraction NoticeSource: Retraction Watch database
Study on corporate vitality from perspective of dynamic capabilities view
10.1109/icpim.2011.5983607 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 10205
Rationale: Breach of Policy by Author;Date of Article and/or Notice Unknown;Notice - Limited or No Information
About Author: Yanmei Xu
Retraction NoticeSource: Retraction Watch database
Immune cell functional assay in monitoring of adult liver transplantation recipients with infection
10.1097/tp.0000000000002824 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 20944
Rationale: Ethical Violations by Author;Informed/Patient Consent - None/Withdrawn;Investigation by Company/Institution;Lack of IRB/IACUC Approval and/or Compliance;Removed
About Author: Feng Xue
Retraction NoticeSource: Retraction Watch database
Camouflage Texture Design Based on Camouflage Performance Evaluation
10.1016/j.neucom.2019.09.015 (opens in new tab)RetractionWatch ID:Record identifier in the Retraction Watch database 21311
Rationale: Error in Text
About Author: Feng Xue
Q2.2 — Are there concerns relating to the timing or absence of study registration?
Rationale: Registered just in time
Supporting Evidence (2)
Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)
Registration ID: NCT06199089
Registry: ClinicalTrials.gov
Registry Link: https://clinicaltrials.gov/study/NCT06199089 (opens in new tab)
Registration Date: 09-01-2024
Prospective:Whether the trial was registered before participant recruitment began Yes
Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is on or before LLM recruitment start date.
Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text
Recruitment Start: 16-01-2024
Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Setting: 'Five hospitals in China, 16 January to 11 June 2024.' indicates the recruitment start date.
Recruitment End: N/A
Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date No explicit last patient in date found.
Study End: 11-06-2024
Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date Setting: 'Five hospitals in China, 16 January to 11 June 2024.' indicates the study end date.
Overall — What is the overall integrity assessment of the study?
Rationale: Too many authors with similar names on RW's database, needs further evaluation.